MedPath

Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Allogeneic Bone-patellar Tendon-bone Transplantation

Not Applicable
Completed
Conditions
Anterior Cruciate Ligament Rupture
Interventions
Procedure: BPTB double-bundle allograft
Procedure: BPTB single-bundle autograft group
Procedure: BPTB single-bundle allograft group
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
84
Registration Number
NCT04951531
Locations
🇨🇳

Institute of Sports Medicine, Peking University Third Hospital, Beijing, Beijing, China

Follow-up of Patients With Talocalcaneal Coalitions

Completed
Conditions
Talocalcaneal Coalition
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
106
Registration Number
NCT04950361

The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules

Phase 2
Conditions
Amyotrophic Lateral Sclerosis
Interventions
Drug: Huolingshengji Granules
First Posted Date
2021-07-06
Last Posted Date
2021-07-08
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
144
Registration Number
NCT04950933
Locations
🇨🇳

Peking University Third Hospital, Beijin, China

Development and Validation of a Bowel-routine-based Self Report Questionnaire for Sacral Sparing After Spinal Cord Injury

Completed
Conditions
Spinal Cord Injuries
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
102
Registration Number
NCT04951297

Study on the Effectiveness and Safety of Nitrone for Injection in Patients With Acute Ischemic Stroke

Not Applicable
Conditions
Acute Ischemic Stroke
Interventions
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
200
Registration Number
NCT04951440
Locations
🇨🇳

: Beijing Dan's self technology co., LTD., Beijing, China

🇨🇳

Tiantan Hospital, Capital Medical University, Beijing, China

Phase III Clinical Trial of Y-2 Sublingual Tablets in the Treatment of Acute Ischemic Stroke

Phase 3
Completed
Conditions
Stroke
Interventions
Drug: Y-2 sublingual tablets
First Posted Date
2021-07-06
Last Posted Date
2023-08-22
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
914
Registration Number
NCT04950920
Locations
🇨🇳

Peking University Third Hospital, Beijin, China

Clinical Trials of Prosthesis and Surgery Guide System

Not Applicable
Conditions
Knee Osteoarthritis
Interventions
Device: Personalized TKA prosthesis
Device: Zimmer NexGen prostheses
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
10
Registration Number
NCT04950348
Locations
🇨🇳

Institute of Sports Medicine, Peking University Third Hospital, Beijing, Beijing, China

Clinical Results of Arthroscopic Repair for Massive Rotator Cuff Tears of 14 Cases

Completed
Conditions
Rotator Cuff Tears
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
14
Registration Number
NCT04951375
Locations
🇨🇳

Peking Univerisity Third Hospital, Beijing, Beijing, China

Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke

Phase 4
Conditions
Acute Ischemic Stroke
Interventions
Drug: Shuxinin injection
Drug: Basic treatment
Drug: Placebo
First Posted Date
2021-07-06
Last Posted Date
2021-07-07
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
480
Registration Number
NCT04950790
Locations
🇨🇳

Peking University Third Hospital, Beijing, China

Study on the Rehabilitation Treatment of Knee Osteoarthritis Based on ICF

Conditions
Knee Osteoarthritis
Interventions
Diagnostic Test: ICF core set
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
600
Registration Number
NCT04951414
Locations
🇨🇳

Capital clinical characteristic applied research and achievement promotion, Beijing, Beijing, China

🇨🇳

Huarunwugang general hospital, Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath